Gufic Biosciences Limited

BSE:509079 Stok Raporu

Piyasa değeri: ₹44.2b

Gufic Biosciences Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Gufic Biosciences has been growing earnings at an average annual rate of 26.1%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 17.6% per year. Gufic Biosciences's return on equity is 16.2%, and it has net margins of 10.6%.

Anahtar bilgiler

26.1%

Kazanç büyüme oranı

22.8%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı17.6%
Özkaynak getirisi16.2%
Net Marj10.6%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Gufic Biosciences nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:509079 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 248,1458641,1530
31 Mar 248,0678611,1320
31 Dec 237,8478421,0920
30 Sep 237,6048231,0260
30 Jun 237,2047939600
31 Mar 236,9067979400
31 Dec 226,7988199220
30 Sep 226,7448268960
30 Jun 226,9378578960
31 Mar 227,7929589130
31 Dec 217,4898848650
30 Sep 217,4348298530
30 Jun 216,7777697820
31 Mar 214,8774426910
31 Dec 204,0053055880
30 Sep 203,5382435570
30 Jun 203,1951234990
31 Mar 203,7882276370
31 Dec 193,6812435780
30 Sep 193,5802325740
30 Jun 193,6402494790
31 Mar 193,5082195250
31 Dec 183,3341645270
30 Sep 183,3531685200
30 Jun 183,1921646110
31 Mar 183,0561654790
31 Dec 172,8871814920
30 Sep 172,6511544550
30 Jun 172,5441244320
31 Mar 172,455904270
31 Dec 162,4191054020
30 Sep 162,329983790
30 Jun 162,201883450
31 Mar 162,022733320
31 Dec 151,806625350
30 Sep 151,588454970
30 Jun 151,500362310
31 Mar 151,516422120
31 Dec 141,533433850
30 Sep 141,503473820
30 Jun 141,366471420
31 Mar 141,230433390
31 Dec 131,104373350

Kaliteli Kazançlar: 509079 has high quality earnings.

Büyüyen Kar Marjı: 509079's current net profit margins (10.6%) are lower than last year (11%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 509079's earnings have grown significantly by 26.1% per year over the past 5 years.

Büyüme Hızlandırma: 509079's earnings growth over the past year (8.9%) is below its 5-year average (26.1% per year).

Kazançlar vs. Sektör: 509079 earnings growth over the past year (8.9%) did not outperform the Pharmaceuticals industry 19.1%.

Özkaynak Getirisi

Yüksek ROE: 509079's Return on Equity (16.2%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y